Literature DB >> 9499768

Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study.

P Mitchell1, W Smith, J J Wang, K Attebo.   

Abstract

OBJECTIVE: This study aimed to determine the prevalence and characteristics of diabetic retinopathy (DR) in a defined older Australian population.
DESIGN: A total of 3654 persons 49 years of age or older, 88% of permanent residents from an urban area west of Sydney, underwent a detailed eye examination. This included detailed medical history, Zeiss stereo retinal photography, fasting blood glucose, and other blood factors. The diagnosis of DR was made clinically and from photographic grading in persons with a history or biochemical evidence of diabetes.
RESULTS: Diabetes was present in 7% (95% confidence interval, 6.2-7.8) of the population. Signs of DR were found in 82 participants (2.3%; 95% confidence interval, 1.9-2.8). The prevalence was 1.7% in persons younger than 60 years of age, 2.4% in persons 60 to 69 years of age, 2.7% in persons 70 to 79 years of age, and 2.3% in persons 80 years of age or older. There was no significant gender difference in prevalence. After adjusting for age, gender, and the duration since diagnosis of diabetes, higher blood glucose was related to the finding of moderate-to-severe retinopathy (Wisconsin levels 4-7) compared to milder retinopathy (Wisconsin levels 1.5-3). No association was found between the presence of any retinopathy and blood glucose, a history of hypertension or elevated blood pressure, body-mass index, blood lipids, creatinine, or coagulation factors.
CONCLUSIONS: This Australian study has found similar prevalence rates for DR to a recent U.S. population-based study but lower rates for vision-threatening retinopathy than from clinic-based reports. Previous reports of a relationship between advanced retinopathy and blood glucose were supported. Other than diabetes duration and insulin treatment, no other associations with retinopathy were found.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499768     DOI: 10.1016/S0161-6420(98)93019-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  47 in total

Review 1.  Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure.

Authors:  Jost B Jonas; Liang Xu; Jie Xu; Wen Bin Wei; Ya Xing Wang
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

2.  Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema.

Authors:  Ingrid U Scott; Neil M Bressler; Susan B Bressler; David J Browning; Clement K Chan; Ronald P Danis; Matthew D Davis; Craig Kollman; Haijing Qin
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

3.  Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?

Authors:  C Sabanayagam; G Liew; E S Tai; A Shankar; S C Lim; T Subramaniam; T Y Wong
Journal:  Diabetologia       Date:  2009-04-22       Impact factor: 10.122

Review 4.  Current state of care for diabetic retinopathy in India.

Authors:  Kim Ramasamy; Rajiv Raman; Manish Tandon
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

5.  Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project.

Authors:  R McKay; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

6.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

7.  Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.

Authors:  U H M Spandau; G Sauder; U Schubert; H-P Hammes; J B Jonas
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

8.  Retinopathy among type 2 diabetic patients seen at a tertiary hospital in Nigeria: a preliminary report.

Authors:  Adeyinka Ashaye; Ayodeji Arije; Modupe Kuti; Bolutife Olusanya; Ezekiel Ayeni; Adesoji Fasanmade; Kehinde Akinlade; Millicent Obajimi; Jokotade Adeleye
Journal:  Clin Ophthalmol       Date:  2008-03

9.  The Beijing Desheng Diabetic Eye Study: rationale, design, methodology and baseline data.

Authors:  Yun-Yun Li; Xiu-Fen Yang; Hong Gu; Xi-Pu Liu; Torkel Snellingen; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

10.  Diabetic retinopathy in a multi-ethnic cohort in the United States.

Authors:  Tien Yin Wong; Ronald Klein; F M Amirul Islam; Mary Frances Cotch; Aaron R Folsom; Barbara E K Klein; A Richey Sharrett; Steven Shea
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.